WuXi AppTec Co., Ltd. (SHA:603259)
China · Delayed Price · Currency is CNY 93.81
-0.79 (-0.84%)
Feb 4, 2026, 1:15 PM CST
WuXi AppTec Revenue
WuXi AppTec had revenue of 20.41B CNY in the half year ending June 30, 2025, with 8.13% growth. This brings the company's revenue in the last twelve months to 43.88B, up 23.17% year-over-year. In the year 2024, WuXi AppTec had annual revenue of 37.92B, down -1.97%.
Revenue (ttm)
43.88B
Revenue Growth
+23.17%
P/S Ratio
6.43
Revenue / Employee
1.11M
Employees
37,832
Market Cap
282.13B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 37.92B | -760.22M | -1.97% |
| Dec 31, 2023 | 38.68B | -676.78M | -1.72% |
| Dec 31, 2022 | 39.35B | 16.45B | 71.84% |
| Dec 31, 2021 | 22.90B | 6.37B | 38.50% |
| Dec 31, 2020 | 16.54B | 3.66B | 28.46% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Dian Diagnostics Group | 10.50B |
| Shanghai Runda Medical Technology | 7.40B |
| Hangzhou Tigermed Consulting | 6.56B |
| Guangzhou Kingmed Diagnostics Group | 6.11B |
| BGI Genomics | 3.71B |
| Maccura Biotechnology Co.Ltd | 2.21B |
| Joinn Laboratories(China)Co.,Ltd. | 1.67B |
| Beijing Strong Biotechnologies,Inc. | 1.43B |